Quick Answer
Pasithea Therapeutics Corp. reported Gross Profit of -$2.2 thousand for the year ending 2021.
- This data is from Pasithea Therapeutics Corp.'s annual report (Form 10-K), filed with the SEC on March 30, 2022.
- XBRL data for this metric is available from 2021 to 2021 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $721.00 | Q2 2022: -$1.5 thousand | Q3 2022: $132.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: